Travere Therapeutics, Inc. (TVTX) Analyst Forecast

$24.64

north_east
$0.42 (1.73%)
Day's range
$24.37
Day's range
$25.4

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
09/10/2025 Jefferies Maury Raycroft $35.00 $27.31   28.16%
10/31/2024 Evercore ISI Liisa Bayko $33.00 $17.50   88.57%
10/21/2024 Wells Fargo Mohit Bansal $27.00 $17.87   51.09%
10/10/2024 Evercore ISI Liisa Bayko $30.00 $18.07   66.02%
10/09/2024 Bank of America Securities Jason Zemansky $20.00 $15.21   31.49%
10/01/2024 Barclays Carter Gould $18.00 $13.99   28.66%
09/27/2024 Guggenheim Vamil Divan $23.00 $15.04   52.93%
09/27/2024 H.C. Wainwright Ed Arce $18.00 $15.04   19.68%
09/27/2024 Bank of America Securities Greg Harrison $18.00 $14.01   28.48%
09/10/2024 Canaccord Genuity Ed Nash $23.00 $12.70   81.17%
09/09/2024 Guggenheim Vamil Divan $25.00 $6.31   296.2%
08/28/2024 Piper Sandler Nicole Gabreski $12.00 $8.96   33.93%
08/02/2024 H.C. Wainwright Ed Arce $20.00 $4.62   332.9%
05/07/2024 Canaccord Genuity Ed Nash $18.00 $3.28   448.78%
04/24/2024 H.C. Wainwright Ed Arce $19.00 $2.74   593.43%

Travere Therapeutics, Inc. FAQ's

Travere Therapeutics, Inc. has been rated by research analysts at Jefferies, Evercore ISI, Wells Fargo, Bank of America Securities, Barclays, Guggenheim in the past 90 days.